Viewing nowQzetas Oral Disintegrating Tablet 20 mg (Zastaprazan Citrate)
Zastaprazan Citrate 20mg
Orally disintegrating Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

MFDS item code 202502823 · Approved 2025.10.31 · Insurance code 645406620
Treatment of gastric ulcers and erosive gastroesophageal reflux disease
This medication is used for the treatment of erosive gastroesophageal reflux disease and gastric ulcers.
This medicine is administered to adults as follows. It may be taken with or without food. 1. Treatment of erosive gastroesophageal reflux disease - Take 20 mg orally once daily for 4 weeks. If the condition is not resolved, continue treatment for an additional 4 weeks. 2. Treatment of gastric ulcers - Take 20 mg orally once daily for up to 8 weeks. This medicine is an orally disintegrating tablet. Place it on the tongue and allow it to dissolve in saliva, or take it with water.
This medicine should not be taken by individuals who have allergic reactions to this medicine or its components or have had such experiences in the past. Additionally, it is safer not to use this medicine for individuals who are taking certain antiviral drugs or women who are pregnant or breastfeeding. Those with liver or kidney function problems should exercise special caution when using this medicine, and elderly patients should also take it carefully. Taking this medicine may lead to various side effects such as dyspepsia, abdominal pain, diarrhea, headache, and skin rash, so if any abnormal symptoms occur, it is essential to consult a doctor immediately. Since this medicine reduces stomach acid, there is a slightly increased risk of bacterial infections in the stomach, and there may be risks of osteoporosis fractures and hypomagnesemia with long-term use, so caution is required. Long-term use may lead to vitamin B12 deficiency, so regular testing is recommended. If symptoms suggestive of malignant tumors are present, it is essential to determine cancer status before taking this medicine, and this medicine should be used only for the necessary minimum dosage and duration. This medicine may interact with other medications, so it is crucial to inform your healthcare provider about any currently taken medications, especially when taken together with specific antiviral drugs or antibiotics. Pregnant or breastfeeding women should not take this medicine, and the safety for children and adolescents has not been established. In case of overdose, no specific toxic symptoms have been reported, but if symptoms occur, immediate medical assistance should be sought. This medicine should be stored out of the reach of children, and transferring it to another container is not advisable for maintaining quality.
inguinal hernia, indigestion, chronic gastritis, erosive gastritis, nausea, abdominal distension, abdominal pain, epigastric pain, diarrhea, duodenal polyps, discomfort in the upper abdomen, bloating, food poisoning, gastric polyps, gastritis, hemorrhoids, intestinal metaplasia, esophageal dysplasia, oral abnormal sensation, vomiting, duodenitis, constipation, hypergastrinemia, COVID-19, herpes zoster, bronchitis, molluscum contagiosum, headache, radiculopathy, tension-type headache, tremor, migraine, drowsiness, arthralgia, intervertebral disc disorder of the spine, muscle cramps, limb pain, increased alanine aminotransferase, increased aspartate aminotransferase, increased blood bilirubin, increased blood creatine phosphokinase, increased blood lactate dehydrogenase, increased gamma-glutamyl transferase, increased post-void residual urine volume, weight gain, increased blood gastrin, hypertriglyceridemia, hyperkalemia, hyperlipidemia, rash, pruritus, asthenia, thirst, pain, conjunctival deposits, dry eye syndrome, ligament sprain, bruise, skin laceration, sleep disturbance, thyroid nodule, atrial fibrillation, thrombotic venous inflammation, hematuria, renal cyst, dysmenorrhea, benign pituitary tumor, epigastric pain, indigestion, gastroesophageal reflux disease, nausea, colonic polyps, erosive gastritis, abdominal discomfort, intestinal metaplasia, gingival swelling, belching, passage of blood in stool, abdominal pain, duodenitis, green nail syndrome, nasopharyngitis, influenza, pulmonary tuberculosis, dizziness, lumbar radiculopathy, osteoarthritis, low back pain, allergic conjunctivitis, keratitis, fibula fracture, hyperplastic gallbladder disease, hypertensive heart disease, hypertension, overactive bladder, cough, vocal cord hypertrophy
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly closed container to prevent air or moisture from entering and ideally kept at room temperatures between 1 to 30 degrees Celsius. Storing it this way helps maintain the effectiveness of the medication.
White round oral disintegrating tablet
30 tablets/bottle, 14 tablets/bottle, 28 tablets/box [7 tablets/PTPx4]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowZastaprazan Citrate 20mg
Orally disintegrating Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Zastaprazan Citrate 20mg
Tablet · Prescription medication
Oncologic Therapeutics Co., Ltd.

Zastaprazan Citrate 20mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Zastaprazan Citrate 20mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Zastaprazan Citrate 20mg
Orally disintegrating Tablet · Prescription medication
Onconic Therapeutics Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.